Aviva’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-28,435
| Closed | -$1.19M | – | 994 |
|
|
2021
Q1 | $1.19M | Sell |
28,435
-3,210
| -10% | -$134K | 0.01% | 867 |
|
|
2020
Q4 | $1.47M | Sell |
31,645
-25,655
| -45% | -$1.19M | 0.01% | 771 |
|
|
2020
Q3 | $2.43M | Buy |
57,300
+9,739
| +20% | +$414K | 0.01% | 613 |
|
|
2020
Q2 | $2.28M | Sell |
47,561
-36,882
| -44% | -$1.77M | 0.01% | 720 |
|
|
2020
Q1 | $3.88M | Buy |
+84,443
| New | +$3.88M | 0.03% | 472 |
|